Treatments for overactive bladder.
Newton
M
M
Shenandoah University, Division of Nursing, Winchester, VA, USA.
Kosier
J H
JH
Smith
D
D
D001559:Benzhydryl Compounds / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003408:Cresols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use; D010665:Phenylpropanolamine; D013644:Tartrates / Q000627:therapeutic use; D000068737:Tolterodine Tartrate; D014549:Urinary Incontinence / Q000209:etiology / Q000628:therapy*
D001559:Benzhydryl Compounds; D018680:Cholinergic Antagonists; D003408:Cresols; D008333:Mandelic Acids; D013644:Tartrates; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin